The value of re-import of composite diagnostic or laboratory reagents to Canada indicates a downward trend from 2024 to 2028, starting at $1.6897 million and declining to $0.8585 million. This represents a noticeable annual decrease with the largest decline occurring between 2027 and 2028.
- Year-on-year reduction from 2024 to 2025 is approximately 12.7%.
- From 2025 to 2026, the decline is around 14.2%.
- The period between 2026 and 2027 sees a drop of about 16.2%.
- Finally, a reduction of nearly 19% is noted from 2027 to 2028.
The compound annual growth rate (CAGR) over this period is approximately -15%, suggesting a steady annual decrease on average. In 2023, this value stood notably higher than projected 2028 levels.
Future trends to monitor include the development of domestic production capabilities, potential changes in trade policies, and fluctuations in global demand which could impact re-import dynamics. Additionally, technological advancement in reagent formulation or substitution may further influence these trends.
